Figures and Tables
From the following article:
Challenges and successes in developing new therapies for hepatitis C
Raffaele De Francesco & Giovanni Migliaccio
Nature 436, 953-960(18 August 2005)
doi:10.1038/nature04080
Figure 1
The structures of inhibitors BILN 2061 and VX-950 and of the NS3 serine protease domain (green) complexed with the central domain of NS4A (red).
Full size figure and legend (29K)Figure 2
Examples of inhibitors of the HCV RNA-dependent RNA polymerase.
Full size figure and legend (33K)Figure 3
The crystal structure of the NS5B RNA-dependent RNA polymerase.
Full size figure and legend (70K)


